Newslist

Cynthia Sharma, head of the Chair of Molecular Infection Biology II and spokesperson for the Research Centre for Infectious Diseases, has been recognised with an ERC Consolidator Grant worth two million euros.

On January 12, the Bavarian State Minister of Science, Bernd Sibler received an overview of ongoing SARS-CoV-2 research in Würzburg.

Bavaria is funding the training of future leaders in RNA-based medicine as part of its Elite Network initiative.

Once again, IMIB Director Jörg Vogel has been recognized as a highly cited researcher in his field. This was the result of an evaluation by Clarivate Analytics, a company specializing in citation data.

Cynthia Sharma (IMIB) and Chase Beisel (Helmholtz Institute for RNA-based Infection Research, HIRI) are among the shortlist winners of this year's "Falling Walls Science Breakthroughs of the Year."

Congratulations to Dr. Tina Lence (Faber lab) for receiving an Add-on Fellowship for Interdisciplinary Life Science by the Joachim Herz Foundation.

Cynthia Sharma's team has revealed that the small RNA RepG of the gastric pathogen Helicobacter pylori regulates expression of a gene involved in biosynthesis of bacterial surface structures and thereby also modulates antibiotic sensitivity.

We congratulate Jens Hör from the lab of Jörg Vogel for receiving the 2021 joint PhD award of the Lower Franconian Memorial Year Foundation for Science and the University of Würzburg for his PhD thesis titled “Discovery of RNA/protein complexes by Grad-seq”.

Based on their discovery of non-canonical guide RNAs of the CRISPR/Cas system in the foodborne-pathogen Campylobacter, the labs of Cynthia Sharma (IMIB) and Chase Beisel (HIRI) have developed a novel multiplex diagnostic technology that makes tests for corona and other pathogens much more efficient.

ZINF Juniorgruppenleiterin Sina Bartfeld erklärte beim europäischen Stammzelltag am 5. März 2021 die faszinierenden neuen Modelle aus der Stammzellforschung.

IMIB’s Jörg Vogel and Alexander Westermann provide a comprehensive review on the past, present and future of RNA-sequencing in the context of infections. The review was recently published in Nature Reviews Genetics.

By complementing previous target screens with RNA affinity purification, a formerly overlooked target of the virulence-related Salmonella sRNA PinT is uncovered.

Jörg Vogel, founding director of the Helmholtz Institute for RNA-based Infection Research (HIRI) and director of the Institute for Molecular Infection Biology (IMIB) at the Julius-Maximilians-Universität Würzburg (JMU), is one of the most frequently cited researchers in his field